about
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells.A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenograftsCompensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolismLSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer.Modeling pancreatic cancer with organoidsGenetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL-Kras(G12D/+) ;LSL-Trp53(R172H/+) ;Pdx-1-Cre), Its Variants, and Their Application in Immuno-oncology Drug Discovery.Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic.The small heat shock protein αA-crystallin negatively regulates pancreatic tumorigenesisSafety of palliative chemotherapy in advanced pancreatic cancer.Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.Early detection of pancreatic cancer: Where are we now and where are we going?Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity.Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.Potent antitumor effect of tumor microenvironment-targeted oncolytic adenovirus against desmoplastic pancreatic cancer.Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice.Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.Berries and other natural products in the pancreatic cancer chemoprevention in human clinical trials.Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy for personalized cancer treatment.Animal and cellular models of human disease.Cultured circulating tumor cells and their derived xenografts for personalized oncology.Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant typePersonalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma
P2860
Q30841369-62C3D949-B820-47E1-954A-F4209E16B483Q30850662-738BEABF-B637-49DD-8A78-20496FEA597BQ33882228-FD49FAE6-0969-4454-BE82-92A64DEE5458Q36364191-F7BED4E0-361F-46B3-A228-D4D80B8FFF24Q36842030-95D03B8E-1FBE-45B2-9E2C-64781CA5F286Q37024754-C92101B8-1264-416A-BB3D-6754CAA22511Q37376094-B17DC6E1-F0CE-4939-A014-6188D26A83DBQ37662315-133B4F25-42B3-436A-9E55-C8FB3F35B8BFQ38806041-AEA8E01B-1385-4357-BBDE-68917C6C88B6Q39028343-6B7E0CB4-F4AA-4631-BAA5-37114DA8C61CQ39152619-1C4EFCDC-61A7-4930-B471-71272823A208Q39577399-2716A247-55D2-4BA2-A79C-561F577DB004Q41280277-7DEB4298-ACFA-49BC-AB3E-F8A018125BD4Q41561293-B00A4E10-4BF5-4B35-B11F-08AD58FDE516Q41934085-ACA2FC42-BDD3-466F-8446-D97423BEA1E8Q42314537-22CC4C7F-29B6-425F-A229-9550F422C104Q47142673-83BBA637-5852-46B7-B15D-208265D57382Q49415169-31C25532-31CA-415E-9362-DB694DCD0757Q50080840-C71FCEA2-329A-4C9A-BCC9-73D5C355595DQ50949714-094E564E-4A0B-4997-B0F5-CA1628228DDDQ55059491-5EAE6EB4-04CA-48B2-A192-C500F97569E6Q55474596-247F5FD3-E8D7-423C-BD8F-5BE24072C195Q57091941-A904CFAA-5A2A-493F-AC38-CA2532F2DA10Q58713519-32CC8CE0-36B9-4BCE-A0C7-A709DB28D23A
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Preclinical models of pancreatic ductal adenocarcinoma.
@ast
Preclinical models of pancreatic ductal adenocarcinoma.
@en
type
label
Preclinical models of pancreatic ductal adenocarcinoma.
@ast
Preclinical models of pancreatic ductal adenocarcinoma.
@en
prefLabel
Preclinical models of pancreatic ductal adenocarcinoma.
@ast
Preclinical models of pancreatic ductal adenocarcinoma.
@en
P2860
P356
P1476
Preclinical models of pancreatic ductal adenocarcinoma.
@en
P2093
Hans Clevers
Sylvia F Boj
P2860
P304
P356
10.1002/PATH.4651
P577
2015-09-30T00:00:00Z